Data from: The hidden costs of resistance: contrasting the energetics of successfully and unsuccessfully fighting infection.

When using this data, please cite the original publication:Matthew D. Hall, Ben L. Phillips, Craig R. White, and Dustin J. Marshall (2024) The hidden costs of resistance: contrasting the energetics of successfully and unsuccessfully fighting infection. Functional Ecology.Files in this package:Title: Hall-et-al-FE-metabolic-scaling.csvDescription: Data for the influence of host genotype and infection outcomes on variation in metabolic scaling over three time points. Listed are the individual ID of each animal (ID), the host genotype (Host, HO2 = HU-HO2 or M10 = BE-OMZ-M10), the exposure treatment (Treatment, C1, C14, C19, C20, C24 or CTRL = Unexposed Controls), the outcome of infection (Inf_status, N = animals that were exposed to a pathogen and remained uninfected; Y = animals that were exposed to a pathogen and became infected; and for reference, CON = control animals that were never exposed to the pathogen), the age of the animals at which each metabolic rate measure was made (Time, 10, 20, or 30 days), and at each sampling point, the body mass (Weight_ug, with units of µg), raw metabolic rate (MR_micro, with units of µJ/h), and mass-independent metabolic rates (MR_indep, with units of mJ/h) for each animal.Title: Hall-et-al-FE-energy-use.csvDescription: Data for the influence of host genotype and infection outcomes on variation in initial and overal energy use. Listed are the individual ID of each animal (ID), the host genotype (Host, HO2 = HU-HO2 or M10 = BE-OMZ-M10), the exposure treatment (Treatment, C1, C14, C19, C20, C24 or CTRL = Unexposed Controls), the outcome of infection (Inf_status, N = animals that were exposed to a pathogen and remained uninfected; Y = animals that were exposed to a pathogen and became infected; and for reference, CON = control animals that were never exposed to the pathogen), the VO2 estimates for each individual immediately before they were exposed to a pathogen/placebo suspension (Inital_VO2, with units of mL O2 h-1), and the total energy use as estimated by calculating the difference in VO2 measures throughout the experimental period (Energy_use, with units of mL O2 h-1).

使用本数据时，请引用原始出版物：Matthew D. Hall、Ben L. Phillips、Craig R. White与Dustin J. Marshall（2024）《抗性的隐性代价：成功与未成功抗感染的能量学对比》，《功能生态学》（Functional Ecology）。

本数据包中的文件：

标题：Hall-et-al-FE-metabolic-scaling.csv
描述：关于宿主基因型和感染结果对三个时间点代谢缩放变异影响的数据。列出了每个动物的个体ID（ID）、宿主基因型（Host，HO2=HU-HO2或M10=BE-OMZ-M10）、暴露处理（Treatment，C1、C14、C19、C20、C24或CTRL=未暴露对照组）、感染结果（Inf_status，N=暴露于病原体但未感染的动物；Y=暴露于病原体且感染的动物；作为参考，CON=从未暴露于病原体的对照动物）、测量代谢率时动物的年龄（Time，10、20或30天），以及每个采样点的体重（Weight_ug，单位为µg）、原始代谢率（MR_micro，单位为µJ/h）和质量独立代谢率（MR_indep，单位为mJ/h）。

标题：Hall-et-al-FE-energy-use.csv
描述：关于宿主基因型和感染结果对初始及总体能量使用变异影响的数据。列出了每个动物的个体ID（ID）、宿主基因型（Host，HO2=HU-HO2或M10=BE-OMZ-M10）、暴露处理（Treatment，C1、C14、C19、C20、C24或CTRL=未暴露对照组）、感染结果（Inf_status，N=暴露于病原体但未感染的动物；Y=暴露于病原体且感染的动物；作为参考，CON=从未暴露于病原体的对照动物）、每个个体在暴露于病原体/安慰剂悬液前即刻的VO2估计值（Initial_VO2，单位为mL O2 h⁻¹），以及通过计算实验期间VO2测量值差异得到的总能量使用量（Energy_use，单位为mL O2 h⁻¹）。